NASDAQ:ORMP - Oramed Pharmaceuticals News Headlines

$3.04
+0.04 (+1.33 %)
(As of 09/15/2019 04:00 PM ET)
Today's Range
$2.99
Now: $3.04
$3.02
50-Day Range
$2.86
MA: $3.33
$3.78
52-Week Range
$2.78
Now: $3.04
$5.05
Volume28,545 shs
Average Volume71,980 shs
Market Capitalization$52.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27

Headlines

Oramed Pharmaceuticals (NASDAQ ORMP) News Headlines

Source:
DateHeadline
Short Interest in Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Decreases By 6.7%Short Interest in Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Decreases By 6.7%
www.americanbankingnews.com - September 13 at 8:52 PM
Leonard Sank Purchases 25,000 Shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) StockLeonard Sank Purchases 25,000 Shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Stock
www.americanbankingnews.com - September 11 at 6:49 PM
Oramed Pharmaceuticals (NASDAQ:ORMP) Coverage Initiated at LADENBURG THALM/SH SHOramed Pharmaceuticals (NASDAQ:ORMP) Coverage Initiated at LADENBURG THALM/SH SH
www.americanbankingnews.com - September 11 at 8:05 AM
Oramed to Present at Three Upcoming ConferencesOramed to Present at Three Upcoming Conferences
finance.yahoo.com - September 3 at 8:50 AM
Zacks: Brokerages Anticipate Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Will Announce Quarterly Sales of $830,000.00Zacks: Brokerages Anticipate Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Will Announce Quarterly Sales of $830,000.00
www.americanbankingnews.com - August 31 at 5:34 AM
-$0.28 Earnings Per Share Expected for Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) This Quarter-$0.28 Earnings Per Share Expected for Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) This Quarter
www.americanbankingnews.com - August 29 at 2:08 AM
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Short Interest Down 23.6% in AugustOramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Short Interest Down 23.6% in August
www.americanbankingnews.com - August 27 at 10:09 PM
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Insiders Increased Their HoldingsOramed Pharmaceuticals Inc. (NASDAQ:ORMP) Insiders Increased Their Holdings
finance.yahoo.com - August 17 at 12:07 AM
Friday 7/19 Insider Buying Report: SNES, ORMPFriday 7/19 Insider Buying Report: SNES, ORMP
www.nasdaq.com - July 19 at 7:01 PM
What Kind Of Investor Owns Most Of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)?What Kind Of Investor Owns Most Of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)?
finance.yahoo.com - July 11 at 6:25 PM
Oramed to Present at World Diabetes CongressOramed to Present at World Diabetes Congress
finance.yahoo.com - July 10 at 6:51 PM
ORMP: Phase 2b Trial of ORMD-0801 Fully Enrolled; Data Expected 4Q19…ORMP: Phase 2b Trial of ORMD-0801 Fully Enrolled; Data Expected 4Q19…
finance.yahoo.com - June 25 at 11:48 AM
Oramed Provides Clinical Update with Meaningful Data Expected by Year-EndOramed Provides Clinical Update with Meaningful Data Expected by Year-End
finance.yahoo.com - June 18 at 4:23 PM
Oramed to Present at BIO International ConventionOramed to Present at BIO International Convention
finance.yahoo.com - June 3 at 6:52 PM
Oramed Completes Patient Recruitment of Phase IIb HbA1c Trial for Oral Insulin Capsule ORMD-0801Oramed Completes Patient Recruitment of Phase IIb HbA1c Trial for Oral Insulin Capsule ORMD-0801
finance.yahoo.com - May 21 at 7:26 PM
ORMP: Data from Phase 1 Trial of Oral GLP-1 in 2Q19…ORMP: Data from Phase 1 Trial of Oral GLP-1 in 2Q19…
finance.yahoo.com - May 7 at 7:00 PM
Oramed to Present at ThinkEquity ConferenceOramed to Present at ThinkEquity Conference
finance.yahoo.com - April 29 at 6:42 PM
Introducing Oramed Pharmaceuticals (NASDAQ:ORMP), The Stock That Slid 60% In The Last Five YearsIntroducing Oramed Pharmaceuticals (NASDAQ:ORMP), The Stock That Slid 60% In The Last Five Years
finance.yahoo.com - April 28 at 6:02 PM
Oramed to Present at 3rd Annual Clinical Trials SummitOramed to Present at 3rd Annual Clinical Trials Summit
finance.yahoo.com - April 11 at 9:14 AM
Oramed Patent Allowed in the U.S. for Oral ExenatideOramed Patent Allowed in the U.S. for Oral Exenatide
finance.yahoo.com - April 4 at 8:04 PM
Oramed to Present at H.C. Wainwright Global Life Sciences ConferenceOramed to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 3 at 8:00 PM
Oramed nabs new patent in U.S.Oramed nabs new patent in U.S.
seekingalpha.com - March 28 at 7:25 PM
Oramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery TechnologyOramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery Technology
finance.yahoo.com - March 28 at 7:25 PM
Chinese Regulatory Authority Approves IND Application of Orameds Oral Insulin CapsulesChinese Regulatory Authority Approves IND Application of Oramed's Oral Insulin Capsules
finance.yahoo.com - March 27 at 8:27 AM
Chinese Regulatory Authority [NMPA] Approves IND Application of Orameds Oral Insulin CapsulesChinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules
www.marketwatch.com - March 26 at 7:43 PM
Oramed up 11% on oral insulin studies in ChinaOramed up 11% on oral insulin studies in China
seekingalpha.com - March 26 at 7:43 PM
Oramed Pharmaceuticals IncOramed Pharmaceuticals Inc
www.bloomberg.com - March 19 at 8:38 AM
Frost & Sullivan Publishes Q1 2019 Update on Oramed Pharmaceuticals Inc. - PRNewswireFrost & Sullivan Publishes Q1 2019 Update on Oramed Pharmaceuticals Inc. - PRNewswire
www.prnewswire.com - February 13 at 6:37 PM
Oramed to Present at BIO CEO & Investor ConferenceOramed to Present at BIO CEO & Investor Conference
finance.yahoo.com - February 6 at 6:35 PM
Does The Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Share Price Tend To Follow The Market?Does The Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Share Price Tend To Follow The Market?
finance.yahoo.com - February 6 at 6:35 PM
Oramed Pharmaceuticals Inc.Oramed Pharmaceuticals Inc.
www.barrons.com - January 30 at 7:03 PM
ORMP: Multiple Catalysts in 2019…ORMP: Multiple Catalysts in 2019…
finance.yahoo.com - January 24 at 6:32 PM
Oramed Initiates Phase I Oral GLP-1 Study Under INDOramed Initiates Phase I Oral GLP-1 Study Under IND
finance.yahoo.com - January 22 at 6:24 PM
Oramed Pharma (ORMP) CEO Nadav Kidron Provides Milestone Updates in Letter to Shareholders - StreetInsider.comOramed Pharma (ORMP) CEO Nadav Kidron Provides Milestone Updates in Letter to Shareholders - StreetInsider.com
www.streetinsider.com - January 17 at 8:24 AM
Oramed Pharmaceuticals CEO Letter to Shareholders - PRNewswireOramed Pharmaceuticals' CEO Letter to Shareholders - PRNewswire
www.prnewswire.com - January 17 at 8:24 AM
Oramed Pharmaceuticals CEO Letter to ShareholdersOramed Pharmaceuticals' CEO Letter to Shareholders
finance.yahoo.com - January 15 at 6:08 PM
Oramed Pharma (ORMP) Secures Additional $3M Milestone Payment from HTIT - StreetInsider.comOramed Pharma (ORMP) Secures Additional $3M Milestone Payment from HTIT - StreetInsider.com
www.streetinsider.com - January 10 at 6:05 PM
Oramed Receives Additional $3 Million Milestone Payment from HTITOramed Receives Additional $3 Million Milestone Payment from HTIT
finance.yahoo.com - January 9 at 7:02 PM
ORMP: Two Studies Ongoing for ORMD-0801 with Data Readouts in 2019…ORMP: Two Studies Ongoing for ORMD-0801 with Data Readouts in 2019…
finance.yahoo.com - December 17 at 5:43 PM
Is Oramed Pharmaceuticals Inc’s (NASDAQ:ORMP) CEO Paid Enough Relative To Peers?Is Oramed Pharmaceuticals Inc’s (NASDAQ:ORMP) CEO Paid Enough Relative To Peers?
finance.yahoo.com - November 27 at 5:18 PM
ORMP: Transferring Coverage; Multiple Clinical Readouts for Oral Protein Delivery Technology Over Next 12-18 MonthsORMP: Transferring Coverage; Multiple Clinical Readouts for Oral Protein Delivery Technology Over Next 12-18 Months
finance.yahoo.com - November 15 at 5:25 PM
Oramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical StudyOramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical Study
finance.yahoo.com - November 13 at 5:12 PM
Oramed to Present at the Tides Europe 2018 ConferenceOramed to Present at the Tides Europe 2018 Conference
finance.yahoo.com - November 5 at 8:34 AM
Oramed to Present at Cardiometabolic Health CongressOramed to Present at Cardiometabolic Health Congress
finance.yahoo.com - October 23 at 5:05 PM
Oramed Enrolls First Patient in Its Clinical Study for Oral Insulin in the Treatment of NASHOramed Enrolls First Patient in Its Clinical Study for Oral Insulin in the Treatment of NASH
finance.yahoo.com - October 4 at 4:53 PM
Is Oramed Pharmaceuticals Inc’s (NASDAQ:ORMP) Balance Sheet Strong Enough To Weather A Storm?Is Oramed Pharmaceuticals Inc’s (NASDAQ:ORMP) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - September 20 at 4:55 PM
Form 8-K ORAMED PHARMACEUTICALS For: Sep 17Form 8-K ORAMED PHARMACEUTICALS For: Sep 17
www.streetinsider.com - September 18 at 8:24 AM
Oramed Pharma (ORMP) Announces FDA Clearance for IND Application for Its Oral GLP-1 Analog CapsuleOramed Pharma (ORMP) Announces FDA Clearance for IND Application for Its Oral GLP-1 Analog Capsule
www.streetinsider.com - September 17 at 5:17 PM
Oramed on go to start clinical trials on ORMD-0901Oramed on go to start clinical trials on ORMD-0901
seekingalpha.com - September 17 at 5:17 PM
Oramed Receives FDA Clearance for IND Application for Its Oral GLP-1 Analog CapsuleOramed Receives FDA Clearance for IND Application for Its Oral GLP-1 Analog Capsule
finance.yahoo.com - September 17 at 5:17 PM
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel